Fox S - Search Results

1

Paclitaxel plus gallium nitrate and filgrastim in patients with refractory malignancies: a phase I trial.

Sandler A, Fox S, Meyers T, Christou A, Weber G, Gonin R, Loehrer PJ, Einhorn LH, Dreicer R. Sandler A, et al. Among authors: fox s. Am J Clin Oncol. 1998 Apr;21(2):180-4. doi: 10.1097/00000421-199804000-00018. Am J Clin Oncol. 1998. PMID: 9537208 Clinical Trial.

2

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.

Hudes GR, Greenberg R, Krigel RL, Fox S, Scher R, Litwin S, Watts P, Speicher L, Tew K, Comis R. Hudes GR, et al. Among authors: fox s. J Clin Oncol. 1992 Nov;10(11):1754-61. doi: 10.1200/JCO.1992.10.11.1754. J Clin Oncol. 1992. PMID: 1383436 Clinical Trial.

3

A phase II trial of paclitaxel in refractory germ cell tumors.

Sandler AB, Cristou A, Fox S, Williams SD, Nichols CR, Turns M, Roth BJ. Sandler AB, et al. Among authors: fox s. Cancer. 1998 Apr 1;82(7):1381-6. doi: 10.1002/(sici)1097-0142(19980401)82:7<1381::aid-cncr23>3.0.co;2-1. Cancer. 1998. PMID: 9529032 Clinical Trial.

4

Paclitaxel (Taxol) plus doxorubicin plus filgrastim in advanced sarcoma: a phase II study.

Sandler A, Fox S, Meyers T, Rougraff B. Sandler A, et al. Among authors: fox s. Am J Clin Oncol. 1998 Jun;21(3):241-5. doi: 10.1097/00000421-199806000-00006. Am J Clin Oncol. 1998. PMID: 9626789 Clinical Trial.

5

A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium.

Sweeney CJ, Williams SD, Finch DE, Bihrle R, Foster RS, Collins M, Fox S, Roth BJ. Sweeney CJ, et al. Among authors: fox s. Cancer. 1999 Aug 1;86(3):514-8. doi: 10.1002/(sici)1097-0142(19990801)86:3<514::aid-cncr21>3.0.co;2-9. Cancer. 1999. PMID: 10430261 Clinical Trial.

6

Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.

Haas NB, Giantonio BJ, Litwin S, Minniti CJ Jr, Fox S, Yeslow G, Reilly R, Nahum K, Greenberg R, Halbherr T, Hudes GR. Haas NB, et al. Among authors: fox s. Cancer. 2003 Nov 1;98(9):1837-41. doi: 10.1002/cncr.11734. Cancer. 2003. PMID: 14584064 Free article. Clinical Trial.

7

Testicular cancer.

Brock D, Fox S, Gosling G, Haney L, Kneebone P, Nagy C, Qualitza B. Brock D, et al. Among authors: fox s. Semin Oncol Nurs. 1993 Nov;9(4):224-36. doi: 10.1016/s0749-2081(05)80051-8. Semin Oncol Nurs. 1993. PMID: 8290818 Review.

8

Phase II study of topotecan in metastatic hormone-refractory prostate cancer.

Hudes GR, Kosierowski R, Greenberg R, Ramsey HE, Fox SC, Ozols RF, McAleer CA, Giantonio BJ. Hudes GR, et al. Among authors: fox sc. Invest New Drugs. 1995;13(3):235-40. doi: 10.1007/BF00873806. Invest New Drugs. 1995. PMID: 8729952 Clinical Trial.

9

Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas.

Scher RM, Kosierowski R, Lusch C, Alexander R, Fox S, Redei I, Green F, Raskay B, Amfoh K, Engstrom PF, O'Dwyer PJ. Scher RM, et al. Among authors: fox s. Invest New Drugs. 1996;13(4):347-54. doi: 10.1007/BF00873143. Invest New Drugs. 1996. PMID: 8824355 Clinical Trial.

10

Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas.

Stevenson JP, Scher RM, Kosierowski R, Fox SC, Simmonds M, Yao KS, Green F, Broom C, Fields SZ, Krebs JB, O'Dwyer PJ. Stevenson JP, et al. Among authors: fox sc. Eur J Cancer. 1998 Aug;34(9):1358-62. doi: 10.1016/s0959-8049(98)00053-7. Eur J Cancer. 1998. PMID: 9849417 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,579 results

Search Page

Filters